Delivery Order SPE2DE24D0013-SPE2D625F0LHY
- Not listed
- The Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $4,791.90 to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, identified as 4568960199 / GXCT/NG-10, carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a discrete purchase of molecular diagnostic solutions from Cepheid, a leading manufacturer of advanced...
- The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $13,825.20 firm fixed-price delivery order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. This delivery order, issued on September 19, 2025, with an ultimate completion date of September 26, 2025, carries no set-aside designation and represents a procurement of diagnostic equipment or testing supplies. The award leverages Cepheid's expertise in advanced...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,269.40 firm fixed-price delivery order to Cepheid Inc. on October 31, 2025, with completion targeted for November 7, 2025. This delivery order, designated GXCARBAR-10, represents a continuation of Cepheid's longstanding role as a primary federal supplier of molecular diagnostic solutions, particularly for infectious disease testing and detection capabilities. The contract utilizes no set-aside designation and will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a Delivery Order (Contract No. GXCARBAR-10) valued at $2,039.40 to Cepheid Inc. on October 27, 2025, with ultimate completion by November 3, 2025. This firm fixed-price delivery order, which includes no set-aside designation, represents a task order issued under Cepheid's existing Indefinite Delivery Contract with the DLA Medical Supply Chain. Cepheid, headquartered in Sunnyvale, California, is a manufacturer of advanced molecular...
- The Defense Logistics Agency (DLA) under the Medical Supply Chain division awarded a $13,096.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 29, 2025, and carries no set-aside designation. This award represents procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and...
- The U.S. Defense Logistics Agency (DLA), operating through its Medical Supply Chain division, awarded a $28,786 firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This non-set-aside contract is issued under Cepheid's existing Indefinite Delivery Vehicle (IDV) with the Veterans Integrated Service Network (VISN) 6, a $32.8 million single-award contract that extends through September 30, 2030. The work will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,757.00 firm fixed-price delivery order to Cepheid Inc. on November 5, 2025, with an ultimate completion date of November 20, 2025. This delivery order, issued without a set-aside designation, supports the agency's molecular diagnostic supply requirements and leverages Cepheid's established expertise as a primary federal supplier of diagnostic solutions. The work will be performed at Cepheid's headquarters in Sunnyvale, California....
- The U.S. Defense Logistics Agency (operating as Medical Supply Chain) awarded a delivery order valued at $4,449.60 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 22, 2025. The contract, designated as firm fixed-price with no set-aside designation, has an ultimate completion date of September 29, 2025. This delivery order represents a short-duration procurement typical of the Department of Defense's medical supply chain operations, which...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,440 on September 5, 2025, by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The delivery order, identified as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and calls for completion by September 12, 2025. Based on the contract nomenclature and Cepheid's product portfolio, this delivery order...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0LHYDelivery Order
The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $3,081.60 to Cepheid Inc. on August 7, 2025, for molecular diagnostic solutions. This firm fixed-price delivery order, designated 4569021301 and classified as GXCDIFF/EPI-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The award carries no set-aside designation and represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities for defense-related medical supply operations. Cepheid is a established provider of molecular diagnostic systems and reagents to multiple federal agencies, including the VA, Defense Health Agency, and DLA. The company specializes in GeneXpert diagnostic systems and associated test kits for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus, and other pathogens. This delivery order likely draws from one of Cepheid's existing indefinite delivery vehicle contracts, such as the VA's Veterans Integrated Service Network 6 IDV valued at $32.8 million through September 2030, which supplies molecular diagnostic testing reagents and assays on a continuous basis. The modest order value and compressed performance timeline suggest this represents a specific, immediate procurement need within the military or defense healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/7/25 |